Once again, we confirmed in vivo that BRD7 downregulated PD-L1 expression and inhibited NPC growth by inhibiting the activation of the PI3K/AKT/mTOR/STAT3 signaling pathway. The gene discussed is BRD7; the disease is nasopharyngeal carcinoma.